A Phase 1, Open-Label Study to Assess the Metabolism, Excretion, and Mass Balance of [14C]-Plazomicin Following a Single IV Infusion in Healthy Adult Male Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Plazomicin (Primary)
Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Urinary tract infections
Focus Pharmacokinetics
Sponsors Achaogen

07 Oct 2018 Results assessing pharmacokinetic parameters of plazomicin in Healthy subjects, presented at the IDWeek 2018.
11 Jul 2017 Status changed from active, no longer recruiting to completed.
07 Jul 2017 Planned End Date changed from 30 Jun 2017 to 10 Jul 2017.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com